← FDA Drug Approvals (Drugs@FDA)
Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets
NDA · New Drug Application · Sponsor: STRIDES ACROLAB · Approved 2007-03-02
Drug application
- FDA Application #
NDA021988- Application type
- New Drug Application
- Brand name
- Lamivudine/Zidovudine 150 mg/300 mg Tablets Co-packaged with Nevirapine 200 mg Tablets
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- STRIDES ACROLAB
- First approval
- 2007-03-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown